Curtis Lockshin - 24 Mar 2022 Form 4 Insider Report for Xenetic Biosciences, Inc. (XBIO)

Role
Chief Sciencific Officer
Signature
/s/ Curtis A. Lockshin
Issuer symbol
XBIO
Transactions as of
24 Mar 2022
Net transactions value
$0
Form type
4
Filing time
28 Mar 2022, 17:13:39 UTC
Previous filing
16 Feb 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XBIO Stock Options Award $0 +50,000 $0.000000 50,000 24 Mar 2022 Common Stock 50,000 $1.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 24, 2022; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 24, 2023 and ending on March 24, 2025.